Pain Channel
Topics & Medications
Quicklinks
Related Channels

Vicodin Compared to Darvocet

In November 2010, the United States Food and Drug Administration (FDA) withdrew all medications that contain propoxyphene from the market. It has been determined that the risks of propoxyphene outweigh the possible benefits. In particular, the FDA was concerned about the drug's ability to cause serious changes in the heart rhythm, even at normal doses. Pharmacies will no longer sell this medication, and people who take it should stop and ask their healthcare provider for a more suitable pain medication.
 
Darvocet® (propoxyphene/acetaminophen) is a prescription pain medication that is somewhat similar to Vicodin® (hydrocodone/APAP). Compared to Darvocet, however, Vicodin is generally a stronger painkiller.
 
Darvocet is approved to treat mild-to-moderate pain, while Vicodin is approved to treat moderate-to-moderately severe pain. Vicodin is a Schedule III controlled substance, while Darvocet is a Schedule IV controlled substance. This means that Vicodin is more likely to be abused, compared with Darvocet. However, the prescribing rules for both medications are the same (a prescription for either is good only for a maximum of six months and limited to five refills).
 
Both medications contain a narcotic (propoxyphene napsylate or hydrochloride bitartrate) in combination with acetaminophen. Both are classified as controlled substances, which means they have significant abuse potential. They have similar side effects, drug interactions, and warnings.
 
(Click Darvocet Vs. Vicodin for more information about Vicodin compared to Darvocet, including some of the primary similarities and differences between the drugs.)
 
8 Frequent Pain Syndromes
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.